XANTHOPOULOS KLEANTHIS GABRIEL enters CONNECT BIOPHARMA HOLDINGS LTD with 80K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Ordinary Shares
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 80K | Direct |
| Total | 80K | 80K direct |
Stock Option (Right to Buy)
DirectUnderlying shares
28.36K
Shares owned
N/A
Exercise price
1.27
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
21.27K
Shares owned
N/A
Exercise price
4.12
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
60K
Shares owned
N/A
Exercise price
2.50
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
89.22K
Shares owned
N/A
Exercise price
8.16
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
60K
Shares owned
N/A
Exercise price
0.96
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
46.51K
Shares owned
N/A
Exercise price
1.04
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
33.54K
Shares owned
N/A
Exercise price
1.18
Expiration
—
Exercise window
—
Underlying
338.90K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares | 1.27 | — | — | 28.36K | N/A |
| Stock Option (Right to Buy) Direct | Ordinary Shares | 4.12 | — | — | 21.27K | N/A |
| Stock Option (Right to Buy) Direct | Ordinary Shares | 2.50 | — | — | 60K | N/A |
| Stock Option (Right to Buy) Direct | Ordinary Shares | 8.16 | — | — | 89.22K | N/A |
| Stock Option (Right to Buy) Direct | Ordinary Shares | 0.96 | — | — | 60K | N/A |
| Stock Option (Right to Buy) Direct | Ordinary Shares | 1.04 | — | — | 46.51K | N/A |
| Stock Option (Right to Buy) Direct | Ordinary Shares | 1.18 | — | — | 33.54K | N/A |
| Total | 338.90K | 0.00 | ||||